Literature DB >> 5463737

Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells.

P C Das.   

Abstract

The preparation and investigations of tanned sheep red cells coated with human fibrinogen are presented in detail and noted variables are discussed. Both tanning and coating are quick processes. Higher concentrations of tannic acid improved the sensitivity of the cells but required an increased concentration of stabilizing serum to prevent autoagglutination. Fibrinogen concentration above 2 mug/ml had no significant effect, although a concentration above 100 mug/ml sometimes produced cells with incomplete patterns. The pH of the reaction media may be varied widely, although tanning and coating at a more alkaline pH yielded cells showing an indistinct pattern. Cells prepared by this method can be stored for at least six months.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5463737      PMCID: PMC474480          DOI: 10.1136/jcp.23.2.149

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  ANTIGENICITY OF POLYPEPTIDES (POLY-ALPHA-AMINO ACIDS). V. STUDIES IN RABBITS.

Authors:  P H MAURER; B F GERULAT; P PINCHUCK
Journal:  J Immunol       Date:  1963-03       Impact factor: 5.422

2.  IN VITRO DEMONSTRATION OF ANTI-OVALBUMIN SPECIFICITY OF LYMPH NODE CELLS IN DELAYED TYPE HYPERSENSITIVITY.

Authors:  C STEFFEN; M ROSAK
Journal:  J Immunol       Date:  1963-03       Impact factor: 5.422

3.  FIBRINOGEN-POOR PLATELETS AS ONE OF THE DEFECTS IN GLANZMANN PURPURA.

Authors:  H C FERREIRA; M P SILVA; L G MURAT; C N FERRAZ
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1964 Nov-Dec

4.  Factors influencing haemagglutination tests with tetanux antitoxin.

Authors:  A J FULTHORPE
Journal:  Immunology       Date:  1959-04       Impact factor: 7.397

5.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

6.  The hemagglutination test for rheumatoid arthritis. II. The influence of human plasma fraction II (gamma globulin) on the reaction.

Authors:  G HELLER; A S JACOBSON; M H KOLODNY; W H KAMMERER
Journal:  J Immunol       Date:  1954-01       Impact factor: 5.422

7.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

8.  Fibrinolytic components of human uterine arterial and venous blood.

Authors:  A V Mackay; P C Das; P R Myerscough; J D Cash
Journal:  J Clin Pathol       Date:  1967-05       Impact factor: 3.411

9.  NATURALLY OCCURRING HUMAN ANTIBODY REACTING WITH BENCE JONES PROTEINS.

Authors:  W V EPSTEIN; D GROSS
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Characterization of the reactant (gamma globulin factor) in the F II precipitin reaction and the F II tanned sheep cell agglutination test.

Authors:  C L CHRISTIAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

View more
  10 in total

1.  Studies on hypo- and hypercoagulability. II. Coagulation and fibrin analyses in severe infectious and toxic conditions.

Authors:  F Kunz; H Hörtnagl; G Kroesen; W Schennach; D Egg; E Rumpl; R Aschauer; F Holzknecht
Journal:  Blut       Date:  1974-05

2.  Studies on hypo- and hypercoagulability. I. Evidence for the occurrence of "incomplete" consumption coagulopathy.

Authors:  F Kunz; H Hörtnagl; G Kroesen; E Rumpl; F Holzknecht
Journal:  Blut       Date:  1974-01

3.  Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J D Cash; J S Robson
Journal:  Br Med J       Date:  1972-07-29

4.  Plasminogen assay by a haemagglutination inhibition technique.

Authors:  C A Ludlam; P C Das
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

5.  Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.

Authors:  P C Das
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

6.  Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J J Petrie; J D Cash; J S Robson
Journal:  Br Med J       Date:  1971-08

7.  Production and Purification of Rabbit's Polyclonal Antibody Against Factor VIII.

Authors:  Simin Sohrabi; Azim Akbarzadeh; Dariush Norouzian; Ali Farhangi; Mehri Mortazavi; Mohammad Reza Mehrabi; Mohsen Chiani; Zahra Saffari; Soheil Ghassemi
Journal:  Indian J Clin Biochem       Date:  2011-06-08

8.  Anti-collagen antibodies in sera from rheumatoid arthritis patients.

Authors:  H K Beard; R Ryvar; J Skingle; C L Greenbury
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

9.  Menstrual blood loss and fibrin degradation products.

Authors:  S K Cole; A R Clarkson
Journal:  Br Med J       Date:  1972-01-08

10.  Immunochemical localization of collagen types and proteoglycan in pig intervertebral discs.

Authors:  H K Beard; R Ryvar; R Brown; H Muir
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.